What do systematic reviews say?

Oral iron vs inactive control

It is very uncertain whether oral iron changes mortality compared with inactive control (very low certainty).

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  RR 1.05 [0.68, 1.61]
  4 studies · 659 participants
  Very low

Oral iron vs inactive control

It is very uncertain whether oral iron changes proportion requiring blood transfusion compared with inactive control (very low certainty).

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  RR 0.74 [0.55, 0.99]
  3 studies · 546 participants
  Very low

Oral iron vs inactive control

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 300 participants
  Very low

Oral iron vs inactive control

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 402 participants
  Very low

Oral iron vs inactive control

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 276 participants
  Very low

Oral iron vs inactive control

It is very uncertain whether oral iron changes serious adverse events compared with inactive control (very low certainty).

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  RR 0.96 [0.76, 1.22]
  5 studies · 731 participants
  Very low